Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprascapular Nerve Block for Shoulder Pain in SCI
NCT05364099Phase 4Withdrawn
- Sponsor
- University of Miami
- Start
- Nov 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine and triamcinolone in Chronic shoulder pain, sponsored by University of Miami. Primary endpoints: Global Satisfaction Rating at 1 month and Treatment related adverse events at 12 months. Planned start Nov 2023; status: withdrawn.
02
Drugs
lidocainetriamcinolone
03
Conditions
Chronic shoulder pain
Beyond the preview
Go deeper on NCT05364099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05364099.